In the United States,<unk>  is indicated for the treatment of partial-onset seizures in adults. In the European Union, it is indicated for the adjunctive treatment of focal-onset seizures with or without secondary generalization in adults with epilepsy who have not been adequately controlled despite a history of treatment with at least two anti-epileptic medications.
Cenobamate
Tetrabamate
Felbamate
Topiramate
Retigabine
Tiagabine
Phenylpiracetam
Lamotrigine